| Literature DB >> 31775208 |
Jun Young Yang1, Chan Woo Kim1, Jang Won Lee1, Seung Ki Kim2, Seung Ah Lee2, Euna Hwang1.
Abstract
BACKGROUND: In recent years, breast implants have been frequently placed in the subcutaneous pocket, in the so-called prepectoral approach. We report our technique of prepectoral implant-based breast reconstruction (IBR), as well as its surgical and aesthetic outcomes, in comparison with subpectoral IBR. We also discuss relevant considerations and pitfalls in prepectoral IBR and suggest an algorithm for the selection of patients for IBR based on our experiences.Entities:
Keywords: Breast implant; Breast neoplasms; Mammaplasty
Year: 2019 PMID: 31775208 PMCID: PMC6882693 DOI: 10.5999/aps.2019.00353
Source DB: PubMed Journal: Arch Plast Surg ISSN: 2234-6163
Fig. 1.Surgical technique of prepectoral implant-based breast reconstruction
(A) Acellular dermal matrix (ADM) for prepectoral breast reconstruction. A 14×16 cm or 14×18 cm piece of ADM with a 2.5- to 3-mm thickness. (B) The superolateral side of the ADM was cut out and added to the inferolateral side of the ADM to elongate it to completely cover the inferolateral side of the breast implant. A 1- to 2-cm-long cuff of the ADM was folded in a groove pattern to support the breast implant along the inframammary fold. (C) Anterior view of the prepectoral reconstruction. The implant was positioned in the prepectoral space and covered with an ADM mesh. (D) Lateral view of the prepectoral reconstruction. The inferior and superior margins of the ADM were fixed to the underlying deep fascia.
Patients’ demographics in the subpectoral and prepectoral IBR groups
| Variable | Subpectoral reconstruction | Prepectoral reconstruction | P-value |
|---|---|---|---|
| No. of case | 47 | 32 | |
| Patient data | |||
| Age (yr) | 46.40 ± 6.96 | 48.91 ± 8.51 | 0.173 |
| BMI (kg/m2) | 21.25 ± 2.86 | 23.49 ± 3.71 | 0.003 |
| Smoking history | 8 (17.0) | 4 (12.5) | 0.434 |
| Active smoker | 3 (6.4) | 3 (9.4) | 0.894 |
| Ex-smoker | 5 (10.6) | 1 (3.1) | 0.216 |
| Diabetes | 2 (4.3) | 3 (9.4) | 0.359 |
| Two staged IBR | 20 (42.6) | 16 (50.0) | 0.514 |
| Direct to Implant | 27 (57.4) | 16 (50.0) | 0.514 |
| Median follow-up (wk) | 55.9 | 47.7 | |
| Histology | |||
| Invasive tumor | 33 (70.2) | 24 (75.0) | 0.641 |
| DCIS & LCIS | 12 (25.5) | 7 (21.9) | 0.709 |
| No tumor (prophylaxis) | 2 (4.3) | 1 (3.1) | 0.796 |
| Axillary node operation | |||
| Nodal clearance | 8 (17.0) | 1 (3.1) | 0.056 |
| Sentinel node biopsy | 35 (74.5) | 30 (93.8) | 0.028 |
| No axillary surgery | 4 (8.5) | 1 (3.1) | 0.334 |
| Miscellaneous information | |||
| Chemotherapy | 22 (46.8) | 14 (43.8) | 0.789 |
| Adjuvant radiotherapy | 7 (14.9) | 2 (6.3) | 0.235 |
| Specimen weight (g) | 272.03 ± 135.22 | 343.88 ± 138.31 | 0.020 |
| Implant volume (mL) | 284.07 ± 84.22 | 290.94 ± 85.29 | 0.798 |
| TE initial inflation volume (mL) | 167.00 ± 90.97 | 213.57 ± 115.47 | 0.187 |
Values are presented as mean±SD or number (%).
BMI, body mass index; IBR, implant-based breast reconstruction; DCIS, ductal carcinoma in-situ; LCIS, lobular carcinoma in-situ; TE, tissue expander.
P-values area calculated by Student t-test, Pearson chi-square test and Fisher exact test.
Comparison of outcomes between prepectoral and subpectoral IBR
| Variable | Subpectoral reconstruction | Prepectoral reconstruction | P-value | Odds ratio |
|---|---|---|---|---|
| No. of case | 47 | 32 | ||
| Drain | - | |||
| Drain maintain day (day) | 11.06 ± 5.33 | 8.48 ± 2.72 | 0.009 | |
| Total drain volume (mL) | 866 ± 674 | 745 ± 622 | 0.419 | |
| Pain score | ||||
| NRS (0–10) | 7.17 ± 1.44 | 1.78 (± 1.79) | < 0.001 | - |
| Postoperative complications (≤ 90 day) | ||||
| Infection | 1 (2.1) | 1 (3.1) | 0.782 | - |
| Seroma | 3 (6.4) | 10 (31.3) | 0.003 | 6.67 |
| Hematoma | 7 (14.9) | 0 | 0.038 | 0 |
| Flap necrosis | 6 (12.8) | 4 (12.5) | 0.972 | - |
| Implant failure | 1 (2.1) | 1 (3.1) | 0.782 | - |
| Delayed wound healing | 15 (31.9) | 8 (25.0) | 0.507 | - |
| Postoperative complications (> 90 day) | - | |||
| Latent seroma | 1 (2.1) | 2 (6.3) | 0.347 | |
| Infection | 0 | 1 (3.1) | 0.223 | |
| Implant failure | 0 | 0 | - | |
| Aesthetic outcomes | - | |||
| Rippling | 6 (12.8) | 7 (21.9) | 0.284 | |
| Grade I | 0 | 1 (3.1) | 0.226 | |
| Grade IIa | 1 (2.1) | 2 (6.3) | 0.785 | |
| Grade IIb | 3 (6.4) | 2 (6.3) | 0.636 | |
| Grade III | 2 (4.3) | 2 (6.3) | 0.699 | |
| Animation deformity | 4 (8.5) | 0 | 0.090 | |
| Capsular contracture[ | 1 (2.1) | 0 | 0.406 |
Values are presented as mean±SD or number (%).
IBR, implant-based breast reconstruction; NRS, numeric rating scale.
P-values area calculated by Student t-test, Pearson chi-square test and Fisher exact test. Statistically meaningful odds ratio value is described.
Baker’s grade III.
Fig. 2.Implant-based breast reconstruction selection algorithm
MRI, magnetic resonance imaging; TE, tissue expander; NSM, nipple-sparing mastectomy; SSM, skin-sparing mastectomy; TM, total mastectomy.